Summary
The effects of musk-moxa-string therapy on the immune system in man were investigated in 39 patients with scrofula. Before treatment, the numbers of peripheral blood (PB) CD3+ and DC4+ cells and the ratio CD4+/ CD8+ were found to be lower in patients with scrofula than in normal subjects, while those of B cells and DR+ cells were higher. Response of peripheral blood mononuclear cells (PBMC) to phytohemagglutinin (PHA) diminished in patients with scrofula. At month 2–6 of musk-moxa-string therapy the number of PB CD8+ cells showed slight diminution along with significant increaes in CD3+ and CD4+ cells and CD4+/CD8+ ratio in total lymphocytes (P<0.001). In vitro a marked increased blastogenic response to mitogen stimulation with PHA was observed in PBMC of patients with scrofula after treatment (P<0.001). In contrast, B lymphocytes, monocytes, DR+ cells and blastogenic response to concanavalin A and pokeweed mitogen were not influenced by musk-moxa-string therapy.
Similar content being viewed by others
References
Wang XL, et al. Studies on lymphocyte subpopulations and NK cell activities in epileptic patients. J Tongji Med Univ 1989;9:25–8.
1990;28: 150–2.
Edwards D, et al. The immunology of myobacterial diseases. Am Rev Resp Dis 1986;194:1062–71.
Shiratsuchi H, et al. Analysis of T cell subsets by monoclonal antibodies in patients with tuberculosis after in vitro stimulation with purified protein derivative of tuberculin. Clin Exp Immunol 1984;57:271–8.
Warner C, et al. Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. J Immunol 1981;126:1185.
1987;10 (4):211.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Guan-xin, S., Na, S., Hui-fen, Z. et al. Immunomodulation of musk-moxa-string therapy in patients with scrofula. Journal of Tongji Medical University 10, 164–168 (1990). https://doi.org/10.1007/BF02986456
Issue Date:
DOI: https://doi.org/10.1007/BF02986456